LGALS3 and hyperuricemia: Metformin can reduce the severity of hyperuricemia by activating AMPK and its phosphorylation and protecting against IR caused by hyperuricemia in cardiomyocytes, skeletal muscles [111], and associated pathological processes, including increased fibrogenesis (elevated level of Gal-3, procollagen types 1 and 3).